Prospective study of infectious complications in allogeneic hematopoietic stem cell transplant recipients
- 1 May 2011
- journal article
- Published by Wiley in Clinical Transplantation
- Vol. 25 (3) , 468-474
Abstract
Martín‐Peña A, Aguilar‐Guisado M, Espigado I, Parody R, Cisneros JM. Prospective study of infectious complications in allogeneic hematopoietic stem cell transplant recipients. Clin Transplant 2011: 25: 468–474. © 2010 John Wiley & Sons A/S.Abstract: This is a prospective, observational study of a consecutive cohort of allogeneic hematopoietic stem cell transplantation (allo‐HSCT) adult recipients conducted between July 2003 and May 2006, with the aim of identifying the current incidence, etiology, risk factors for infections and associated mortality up to two yr after allo‐HSCT. Seventy‐four episodes of infection were recorded in 38 patients, 50 consecutive adult patients underwent 54 allo‐HSCT. The incidence of infection was 1.36 (68/50) episodes/patient after the first year of transplantation and 1.48 (74/50) episodes/patient after first two yr of transplantation. The most common syndrome was cytomegalovirus (CMV) infection, followed by catheter‐related bloodstream infection and pneumonia. An etiological diagnosis was established in 85.1% of the episodes. Bacteria were the most common etiology (55.5%), followed by viruses (41.3%) and fungi (4.8%). CMV was the most common viral agent (73%), and all fungal infections were caused by molds. Myeloablative conditioning regimen, chronic graft‐versus‐host disease, and medical complications post‐transplant were independent risk factors for infection. The global mortality two yr after transplantation was 32%, and death was infection related in 12%. In spite of advances, infections continue to be a common cause of morbidity and mortality following allo‐HSCT.Keywords
This publication has 27 references indexed in Scilit:
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus GroupClinical Infectious Diseases, 2008
- Clinical features of late cytomegalovirus infection after hematopoietic stem cell transplantationInternational Journal of Hematology, 2008
- Infections in 100 Cord Blood TransplantationsMedicine, 2007
- Invasive Aspergillosis following Hematopoietic Cell Transplantation: Outcomes and Prognostic Factors Associated with MortalityClinical Infectious Diseases, 2007
- An Intervention to Decrease Catheter-Related Bloodstream Infections in the ICUNew England Journal of Medicine, 2006
- Current Trends of Infectious Complications following Hematopoietic Stem Cell Transplantation in a Single CenterJournal of Korean Medical Science, 2006
- Recomendaciones GESITRA-SEIMC y RESITRA sobre prevención y tratamiento de la infección por citomegalovirus en pacientes trasplantadosEnfermedades Infecciosas y Microbiología Clínica, 2005
- 2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with CancerClinical Infectious Diseases, 2002
- Allogeneic BMT in patients above 45 years of age: a single center experienceBone Marrow Transplantation, 2001
- Infection Complicating Bone Marrow Transplantation1994